FDA Approved: PARICALCITOL — Original Application (Accord Healthcare, Inc.)

View source ↗

Summary

FDA approved Accord Healthcare, Inc.'s paricalcitol under its original application NDA207174 for the treatment of secondary hyperparathyroidism in chronic kidne…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperparathyroidism

Drugs mentioned

• Paricalcitol (paricalcitol)

Snippet

ORIG AP for PARICALCITOL (PARICALCITOL)